Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group

Oncology
Robert C ShepardAl Bowen Benson

Abstract

Responses have been observed in several studies of docetaxel as treatment for advanced pancreatic carcinoma. This trial was designed to determine if the addition of docetaxel to gemcitabine therapy produced responses in >/=25% of patients with chemonaive advanced pancreatic cancer. This trial involved patients with biopsy-proven, advanced carcinoma of the pancreas not amenable to surgical resection. Patients received docetaxel 75 mg/m(2) i.v. over 1 h followed by gemcitabine 2,000 mg/m(2) biweekly until progression or intolerable toxicity. The primary endpoint of the trial was to determine the objective response rate with secondary endpoints of progression-free survival and overall survival. Out of the 32 eligible patients, 2 patients had a complete response and 2 patients had a partial response for an observed objective response rate of 12.5% (90% CI: 4.4, 26.4%). Median survival was 4.7 months. Most toxicities were hematologic, with 48% of patients experiencing grade 4 toxicity. The confirmed complete response rate of 6% and partial response rate of 6% is encouraging, but the toxicity of this regimen appears significant. Based upon these results, this combination of gemcitabine and docetaxel is not worthy of further study. Di...Continue Reading

Citations

Jan 13, 2006·Cancer Chemotherapy and Pharmacology·J FeliuM González Barón
Jan 4, 2008·Cancer Chemotherapy and Pharmacology·William SchelmanGeorge Wilding
Apr 3, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y J Chua, J R Zalcberg
May 6, 2008·Anti-cancer Drugs·Xinmiao YangXichun Hu
Mar 4, 2010·The AAPS Journal·Jing LiJessie L-S Au
Feb 6, 2010·World Journal of Gastroenterology : WJG·Soley BayraktarCaio Max Rocha-Lima
Apr 12, 2008·Expert Review of Anticancer Therapy·Andreas Hilbig, Helmut Oettle
Apr 20, 2010·Expert Review of Anticancer Therapy·Daniel Renouf, Malcolm Moore
Mar 26, 2011·Clinics and Research in Hepatology and Gastroenterology·Isabelle TrouilloudJulien Taieb
Mar 22, 2006·Best Practice & Research. Clinical Gastroenterology·Yu Jo Chua, David Cunningham
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manfred P LutzUNKNOWN European Organisation for Research and Treatment of Cancer Gastrointestinal Group
Feb 3, 2016·F1000Research·Martin L AshdownBrendon J Coventry
Aug 7, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wen Wee Ma, Manuel Hidalgo
Jun 11, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philip A PhilipJohn Crowley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Margaret TemperoJames L Abbruzzese
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Eric Van CutsemD D Von Hoff
© 2022 Meta ULC. All rights reserved